|
1
|
Surfactant based nanoreactor micellar assembly: An innovative route for synthesis of 2-thioxo-2,3-dihydroquinazolin-4(1H)-ones. J Mol Liq 2022. [DOI: 10.1016/j.molliq.2022.119305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
|
2
|
Hajimiri M, Khosravikia M, Khoshneviszadeh M, Pedrood K, Hosseini SZ, Asgari MS, Pirhadi S, Attarroshan M, Mobaraki K, Hosseini S, Behnammanesh H, Biglar M, Karimian S, Rastegar H, Hamedifar H, Larijani B, Mahdavi M, Iraji A. Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin-4(3H)-One Containing Different Aryl Acetohydrazides as Tyrosinase Inhibitors. Chem Biodivers 2022; 19:e202100964. [PMID: 35675562 DOI: 10.1002/cbdv.202100964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Accepted: 05/18/2022] [Indexed: 11/07/2022]
Abstract
Tyrosinase plays a pivotal role in the hyperpigmentation and enzymatic browning of fruit and vegetable. Therefore, tyrosinase inhibitors can be of interest in industries as depigmentation compounds as well as anti-browning agents. In the present study, a series of chlorophenylquinazolin-4(3H)-one derivative were rationally designed and synthesized. The formation of target compounds was confirmed by spectral characterization techniques such as IR, 1 H-NMR, 13 C-NMR, and elemental analysis. Among the synthesized derivatives, compound 8l was proved to be the most potent inhibitor with an IC50 value of 25.48±1.19 μM. Furthermore, the results of the molecular docking study showed that this compound fitted well in the active site of tyrosinase with the binding score of -10.72.
Collapse
Affiliation(s)
- Mirhamed Hajimiri
- CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran
| | - Mohammad Khosravikia
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran
| | - Mehdi Khoshneviszadeh
- Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Keyvan Pedrood
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Seyedeh Zahra Hosseini
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran
| | | | - Somayeh Pirhadi
- Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mahshid Attarroshan
- Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Koroush Mobaraki
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran
| | - Samanesadat Hosseini
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Hossein Behnammanesh
- Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mahmood Biglar
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Somayeh Karimian
- Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Hossein Rastegar
- Cosmetic Products Research Center, Iranian Food and Drug Administration, MOHE, Tehran, Iran
| | - Haleh Hamedifar
- CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran
| | - Bagher Larijani
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Aida Iraji
- Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.,Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|
|
3
|
Sepehri N, Iraji A, Yavari A, Asgari MS, Zamani S, Hosseini S, Bahadorikhalili S, Pirhadi S, Larijani B, Khoshneviszadeh M, Hamedifar H, Mahdavi M, Khoshneviszadeh M. The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activity. Bioorg Med Chem 2021; 36:116044. [DOI: 10.1016/j.bmc.2021.116044] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2020] [Revised: 01/09/2021] [Accepted: 01/20/2021] [Indexed: 01/13/2023]
|
|
4
|
Tashrifi Z, Mohammadi-Khanaposhtani M, Biglar M, Larijani B, Mahdavi M. Isatoic Anhydride: A Fascinating and Basic Molecule for the Synthesis of Substituted Quinazolinones and Benzo di/triazepines. CURR ORG CHEM 2019. [DOI: 10.2174/1385272823666190701142930] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
This review article is focused on the synthesis of compounds with quinazolinones and benzo di/triazepine scaffolds. These invaluable derivatives are of great interest in medicinal and pharmaceutical studies because of their important biological properties. Quinazolinones have diverse applications due to their antibacterial, analgesic, antiinflammatory, antifungal, antimalarial, antihypertensive, CNS depressant, anticonvulsant, antihistaminic, antiparkinsonism, antiviraland and anticancer activities. On the other hand, pharmacological properties of benzodiazepines include antianxiety, anticancer, anticonvulsant, antagonists of cholecystokinin receptors (CCK), antileishmanial, sleep-inducing muscle relaxant and several other useful and interesting properties. As an example, three main categories of drugs, namely anxiolytics, sedative hypnotics (sleep inducers) and anticonvulsants are constructed by 1,4-benzodiazepines. Finally, benzotriazepines are believed to possess various pharmacological properties such as antipsychotic and antitumor activities. Hence, this review is divided into three major sections, considering quinazolinones, benzodiazepines and benzotriazepines. In the first section, we take a brief look at various approaches towards synthesis of substituted quinazolin-4(3H)-ones and 2,3-dihydroquinazolin-4(1H)-ones. Also in this section, we try to give an overview of the synthetic routes and strategies recently reported for the generation of various classes of substituted 4(3H)-quinazolinones and 2,3-dihydroquinazolin-4(1H)-ones. Accordingly, quinazolin-4(3H)-ones, were subdivided into three major classes: 2-substituted, 3-substituted and 2,3-disubstituted-quinazolinones. 2,3- dihydroquinazolin-4(1H)-ones also were subdivided into six sub-categories: 2-monosubstituted, 2,2- disubstituted, 2,3-disubstituted, 1,2,3-trisubstituted, 2,2,3-trisubstituted 2,3-dihydroquinazolin-4(1H)-ones and boron-containing quinazoline-4(1H)-ones. In the other two sections, we cover the literature related to synthesis of benzo di/triazepine. The most recent developments are highlighted with a special emphasis on new synthetic routes based on isatoic anhydride as starting material.
Collapse
Affiliation(s)
- Zahra Tashrifi
- Department of Chemistry, University of Guilan, Rasht PO Box 41335-1914, Iran
| | | | - Mahmood Biglar
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Bagher Larijani
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
|
5
|
Bahadorikhalili S, Rahimzadeh G, Kianmehr E, Ansari S, Hamedifar H, Mahdavi M. Facile Non-Transition Metal-Catalyzed Synthesis of 2-Thioxo-2,3-dihydroquinazolin-4(1H
)-one Derivatives via One-Pot Multicomponent Reactions. ChemistrySelect 2019. [DOI: 10.1002/slct.201802861] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Affiliation(s)
| | - Golnaz Rahimzadeh
- School of Chemistry; College of Science; University of Tehran, P. O. Box:14155-6455; Tehran Iran
| | - Ebrahim Kianmehr
- School of Chemistry; College of Science; University of Tehran, P. O. Box:14155-6455; Tehran Iran
| | - Samira Ansari
- CinnaGen Medical Biotechnology Research Center; Alborz University of Medical Sciences, Karaj; Iran
| | - Haleh Hamedifar
- CinnaGen Medical Biotechnology Research Center; Alborz University of Medical Sciences, Karaj; Iran
| | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center; Endocrinology and Metabolism Clinical Sciences Institute; Tehran University of Medical Sciences; Tehran 14176 Iran
| |
Collapse
|
|
6
|
Sayahi MH, Saghanezhad SJ, Bahadorikhalili S, Mahdavi M. CuBr-catalysed one-pot multicomponent synthesis of 3-substituted 2-thioxo-2,3-dihydroquinazolin-4(1H
)-one derivatives. Appl Organomet Chem 2018. [DOI: 10.1002/aoc.4635] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Affiliation(s)
| | | | | | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute; Tehran University of Medical Sciences; Tehran 14176 Iran
| |
Collapse
|
|
7
|
An efficient access to 2,3-diarylimidazo[1,2-a]pyridines via silver(I)-catalyzed C-H bond functionalization. MONATSHEFTE FUR CHEMIE 2017. [DOI: 10.1007/s00706-017-1950-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
|
8
|
Rezanejade Bardajee G, Ghaedi A, Hekmat S, Abarashi G, Mahdavi M, Akbarzadeh T. A green and efficient synthesis of 2-thioxoquinazolinone derivatives in water using potassium thiocyanate. J Sulphur Chem 2017. [DOI: 10.1080/17415993.2017.1325891] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
| | - Aseyeh Ghaedi
- Department of Chemistry, Payame Noor University (PNU), Tehran, Iran
| | - Shohreh Hekmat
- Department of Chemistry, Payame Noor University (PNU), Tehran, Iran
| | - Ghazale Abarashi
- Department of Chemistry, Payame Noor University (PNU), Tehran, Iran
| | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Tahmineh Akbarzadeh
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
- Drug Design & Development Research Center, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
|
9
|
MOHAMMADHOSSEINI N, SAEEDI M, MORADI S, MAHDAVI M, FIRUZI O, FOROUMADI A, SHAFIEE A. Synthesis and cytotoxicity of novel thioxo-quinazolino[3,4-$a$]quinazolinones. Turk J Chem 2017. [DOI: 10.3906/kim-1512-80] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
|
10
|
Mahdavi M, Saeedi M, Karimi M, Foroughi N, Hasanshahi F, Alinezhad H, Foroumadi A, Shafiee A, Akbarzadeh T. Synthesis of novel 1,2,3-triazole derivatives of 2,3-dihydroquinazolin-4(1H)-one. MONATSHEFTE FUR CHEMIE 2016. [DOI: 10.1007/s00706-016-1739-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
|
11
|
Arasteh-Fard Z, Dilmaghani KA, Saeedi M, Mahdavi M, Shafiee A. Synthesis of Novel Phthalazino[1,2-b]quinazolinedione Derivatives: Efficient and Practical Reaction of 2-Amino-N′-Arylbenzohydrazides and 2-Formylbenzoic Acids. Helv Chim Acta 2016. [DOI: 10.1002/hlca.201600025] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Zahra Arasteh-Fard
- Department of Chemistry; Faculty of Sciences; Urmia University; Urmia Iran
| | | | - Mina Saeedi
- Medicinal Plants Research Center; Faculty of Pharmacy; Tehran University of Medical Sciences; Tehran Iran
- Persian Medicine and Pharmacy Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Mohammad Mahdavi
- Drug Design and Development Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Abbas Shafiee
- Department of Medicinal Chemistry; Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medical Sciences; Tehran Iran
| |
Collapse
|
|
12
|
Mohammadhosseini N, Moradi S, Khoobi M, Shafiee A. Synthesis of Novel 6-Mercapto-12-phenethyl-quinazolino[3,4-a]quinazolinones. J Heterocycl Chem 2015. [DOI: 10.1002/jhet.2470] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | - Shahram Moradi
- Faculty of Chemistry, Tehran-North Branch; Islamic Azad University; Tehran Iran
| | - Mehdi Khoobi
- Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Abbas Shafiee
- Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medical Sciences; Tehran Iran
| |
Collapse
|